IMGN - ImmunoGen Inc. (IMGN) CEO Mark Enyedy on Q4 2018 Results - Earnings Call Transcript
ImmunoGen, Inc. (IMGN)
Q4 2018 Results Earnings Conference Call
February 08, 2019 08:00 AM ET
Company Participants
Courtney O’Konek - Corporate Communications
Mark Enyedy - President and CEO
Anna Berkenblit - CMO
Rich Gregory - Chief Scientific Officer
Blaine Mckee - Chief Business Officer
Dave Foster - Chief Accounting Officer
Conference Call Participants
John Newman - Canaccord Genuity
Michael Schmidt - Guggenheim
Jessica Fye - JP Morgan
Biren Amin - Jefferies
Debjit Chattopadhyay - HC Wainwright & Co
Andy Hsieh - William Blair
Boris Peaker - Cowen
Jonathan Chang - Leerink
Kennan MacKay - RBC